|
Name |
Microdiplodiasol
|
Molecular Formula | C15H18O7 | |
IUPAC Name* |
(1S,4S,4aS,9aR)-1,4,8,9a-tetrahydroxy-6-(hydroxymethyl)-4a-methyl-1,2,3,4-tetrahydroxanthen-9-one
|
|
SMILES |
C[C@]12[C@H](CC[C@@H]([C@@]1(C(=O)C3=C(C=C(C=C3O2)CO)O)O)O)O
|
|
InChI |
InChI=1S/C15H18O7/c1-14-10(18)2-3-11(19)15(14,21)13(20)12-8(17)4-7(6-16)5-9(12)22-14/h4-5,10-11,16-19,21H,2-3,6H2,1H3/t10-,11-,14-,15-/m0/s1
|
|
InChIKey |
SCOQIJBVVKZZHE-GVARAGBVSA-N
|
|
Synonyms |
Microdiplodiasol; CHEBI:68283; CHEMBL1765409; Q27136776; (1S*,4S*,4aS*,9aR*)-1,4,8,9a-tetrahydroxy-6-(hydroxymethyl)-4a-methyl-1,2,3,4,4a,9a-hexahydro-9H-xanthen-9-one
|
|
CAS | NA | |
PubChem CID | 52937070 | |
ChEMBL ID | CHEMBL1765409 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 310.3 | ALogp: | -0.5 |
HBD: | 5 | HBA: | 7 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 127.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 22 | QED Weighted: | 0.49 |
Caco-2 Permeability: | -5.59 | MDCK Permeability: | 0.00005660 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.965 |
Human Intestinal Absorption (HIA): | 0.149 | 20% Bioavailability (F20%): | 0.148 |
30% Bioavailability (F30%): | 0.981 |
Blood-Brain-Barrier Penetration (BBB): | 0.596 | Plasma Protein Binding (PPB): | 62.72% |
Volume Distribution (VD): | 0.951 | Fu: | 47.59% |
CYP1A2-inhibitor: | 0.016 | CYP1A2-substrate: | 0.114 |
CYP2C19-inhibitor: | 0.011 | CYP2C19-substrate: | 0.094 |
CYP2C9-inhibitor: | 0.003 | CYP2C9-substrate: | 0.175 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.125 |
CYP3A4-inhibitor: | 0.012 | CYP3A4-substrate: | 0.08 |
Clearance (CL): | 3.749 | Half-life (T1/2): | 0.591 |
hERG Blockers: | 0.048 | Human Hepatotoxicity (H-HT): | 0.143 |
Drug-inuced Liver Injury (DILI): | 0.026 | AMES Toxicity: | 0.026 |
Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.741 |
Skin Sensitization: | 0.144 | Carcinogencity: | 0.033 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.024 |
Respiratory Toxicity: | 0.975 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002175 | 0.769 | D0P1FO | 0.281 | ||||
ENC002743 | 0.379 | D03DXN | 0.248 | ||||
ENC002898 | 0.341 | D0L7AS | 0.243 | ||||
ENC003031 | 0.338 | D03BLF | 0.241 | ||||
ENC002598 | 0.333 | D07MGA | 0.237 | ||||
ENC002695 | 0.333 | D04VIS | 0.233 | ||||
ENC002607 | 0.333 | D03YVO | 0.231 | ||||
ENC002159 | 0.333 | D02GAC | 0.228 | ||||
ENC005363 | 0.330 | D0PG8O | 0.226 | ||||
ENC000940 | 0.330 | D0YH0N | 0.223 |